Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke

Bangdiwala, SI; Benz, AP; Bowman, L; Brandes, A; Buck, B; Casadei, B; Chen, LY; Connolly, SJ; Diederichsen, AJ; Diederichsen, SZ; Dolovich, L; Engdahl, J; Engler, D; Freedman, B; Gibson, CM; Gladstone, D; Haeusler, K; Halcox, J; Healey, JS; Hobbs, R; Kaasenbrood, F; Lindholt, JS; Lip, GYH; Lopes, RD; Lubitz, S

Journal article

Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke

Abstract:: INTRODUCTION: Atrial fibrillation (AF) is a common cause of stroke. Timely diagnosis of AF and treatment with oral anticoagulation (OAC) can prevent up to two-thirds of AF-related strokes. Ambulatory electrocardiographic (ECG) monitoring can identify undiagnosed AF in at-risk individuals, but the impact of population-based ECG screening on stroke is uncertain, as ongoing and published randomized controlled trials (RCTs) have generally been underpowered for stroke.METHODS AND ANALYSIS: The AF-SCREEN Collaboration, with support from AFFECT-EU, have begun a systematic review and individual participant data meta-analysis of RCTs evaluating ECG screening for AF. The primary outcome is stroke. Secondary outcomes include AF detection, OAC prescription, hospitalization, mortality, and bleeding.After developing a common data dictionary, anonymized data will be collated from individual trials into a central database. We will assess risk of bias using the Cochrane Collaboration tool, and overall quality of evidence with the Grading of Recommendations Assessment, Development and Evaluation approach.We will pool data using random effects models. Prespecified subgroup and multilevel meta-regression analyses will explore heterogeneity. We will perform prespecified trial sequential meta-analyses of published trials to determine when the optimal information size has been reached, and account for unpublished trials using the SAMURAI approach.IMPACT AND DISSEMINATION: Individual participant data meta-analysis will generate adequate power to assess the risks and benefits of AF screening. Meta-regression will permit exploration of the specific patient, screening methodology, and health system factors that influence outcomes.TRIAL REGISTRATION NUMBER: PROSPERO CRD42022310308.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Bangdiwala, S. I., Benz, A. P., Bowman, L., Brandes, A., Buck, B., Casadei, B., Chen, L. Y., Connolly, S. J., Diederichsen, A. J., Diederichsen, S. Z., Dolovich, L., Engdahl, J., Engler, D., Freedman, B., Gibson, C. M., Gladstone, D., Haeusler, K., Halcox, J., Healey, J. S., … Lubitz, S. (2023). Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke. Thrombosis and Haemostasis, 123(03), 366–376.

MLA Style

Bangdiwala, SI, et al. “Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke.” Thrombosis and Haemostasis, vol. 123, no. 03, 2023, pp. 366–76.

Chicago Style

Bangdiwala, SI, AP Benz, L Bowman, et al. 2023. “Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke.” Thrombosis and Haemostasis 123 (03): 366–76.
Print